For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenues | 0 | 0 | 0* | 0 |
| Cost of sales | 0 | 0 | 0* | 0 |
| Gross profit | 0 | 0 | 0 | 0 |
| General and administrative | 114,389 | 185,876 | 244,434 | 81,683 |
| Professional fees | 306,004 | 289,144 | 246,521 | 454,344 |
| Total operating expenses | 420,393 | 475,020 | 490,955 | 536,027 |
| Operating loss | -420,393 | -475,020 | -490,955 | -536,027 |
| Recovery of previously written off receivables | 0 | - | 14,500* | - |
| Loss on extinguishment of debt | - | - | -41,846.25* | 0 |
| Interest income | 0 | 0 | - | 0 |
| Gain on sale of subsidiary assets | - | - | 0* | 0 |
| Other expense | 0 | 0 | -5,000.75* | - |
| Interest expense | 100,721 | 46,618 | 35,113 | 25,996 |
| Total other income (expense) | -100,721 | -46,618 | -67,460 | -25,996 |
| Net income from discontinued operations | - | - | 0* | - |
| Net loss before income taxes | -521,114 | -521,638 | -558,415* | -562,023 |
| Provision for income taxes | 0 | 0 | 0* | 0 |
| Net loss from continuing operations | - | - | - | -562,023 |
| Net income from discontinued operations, net of taxes | - | - | - | 0 |
| Net gain from continuing operations | - | - | -558,415* | - |
| Net loss | -521,114 | -521,638 | -558,415 | -562,023 |
| Basic EPS | 0 | 0 | -0.004 | 0 |
| Diluted EPS | 0 | 0 | -0.004 | 0 |
| Basic Average Shares | 159,451,482 | 151,713,129 | 147,932,667 | 136,951,495 |
| Diluted Average Shares | 159,451,482 | 151,713,129 | 147,932,667 | 136,951,495 |
Hypha Labs, Inc. (FUNI)
Hypha Labs, Inc. (FUNI)